详细信息

3种中药注射剂治疗冠心病心绞痛的成本-效果分析     被引量:2

Cost-effectiveness Analyses of 3 Kinds of Traditional Chinese Medicinal Injections in the Treatment of Coronary Heart Disease-induced Angina Pectoris Caused

文献类型:期刊文献

中文题名:3种中药注射剂治疗冠心病心绞痛的成本-效果分析

英文题名:Cost-effectiveness Analyses of 3 Kinds of Traditional Chinese Medicinal Injections in the Treatment of Coronary Heart Disease-induced Angina Pectoris Caused

作者:顾秀琰[1];王昕[2]

第一作者:顾秀琰

机构:[1]甘肃省中医院;[2]甘肃中医学院

第一机构:甘肃省中医院

年份:2009

卷号:20

期号:6

起止页码:459

中文期刊名:中国药房

外文期刊名:China Pharmacy

收录:CSTPCD;;北大核心:【北大核心2008】;CSCD:【CSCD_E2011_2012】;

语种:中文

中文关键词:冠心病心绞痛;药物经济学;成本-效果分析;中药注射剂

外文关键词:Coronary heart disease - induced angina pectoris; Pharmacoeconomics; Cost - effectiveness analysis; Traditional Chinese medicinal injection

摘要:目的:评价3种中药注射剂治疗冠心病心绞痛的成本-效果。方法:223例患者分为A、B、C组,分别给予血塞通注射液、注射用灯盏花素、舒血宁注射液进行治疗,观察其疗效并进行成本-效果分析。结果:3种药物的成本分别是1345.50、1768.125、1770.00元;总有效率分别是83.75%、82.09%、85.53%;成本-效果比分别是16.07、21.54、20.69;B、C组相对A组的增量成本-效果比分别是254.60、238.48。结论:血塞通注射液是冠心病心绞痛的较佳治疗药物。
OBJECTIVE: To evaluate the cost- effectiveness of 3 kinds of traditional Chinese medicinal injections in the treatment of angina pectoris caused by coronary heart disease(CHD).METHODS: 223 CHD patients with angina pectoris were divided into 3 groups:group A(Xuesaitong injection),group B(Breviscapine for injection) and group C(Shuxuening injection). The curative effects were observed and the cost effectiveness analyses of the 3 groups were conducted as well.RESULTS:The costs for the 3 groups were 1 345.50 yuan, 1 768.125 yuan, 1 770.00 yuan, respectively; the total effective rates were 83.75%, 82.09% and 85.53%, respectively; the cost-effectiveness ratios were 16.07, 21.54 and 20.69, respectively; the incremental cost- effectiveness ratios of group B and C were 254.60 and 238.48, respectively as against group A. CONCLUSION: Xuesaitong injection(group A) is the preferred therapy for angina pectoris caused by CHD.

参考文献:

正在载入数据...

版权所有©甘肃中医药大学 重庆维普资讯有限公司 渝B2-20050021-8 
渝公网安备 50019002500408号 违法和不良信息举报中心